Stephen L. Gough
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: September 29, 2022
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials.
Journal: The lancet. Diabetes & endocrinology
Published: February 25, 2022
Reducing hyperglucagonaemia in type 2 diabetes using low-dose glibenclamide: Results of the LEGEND-A pilot study.
Journal: Diabetes, obesity & metabolism
Published: January 20, 2022
The contributions of insulin to science in medicine.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: April 06, 2021
Insulin at 100: still central in protein-based therapy for chronic disease.
Journal: Communications medicine
Published: March 29, 2021
Does Islet Size Really Influence Graft Function After Clinical Islet Transplantation?
Journal: Transplantation
Published: August 01, 2018
Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: August 14, 2015
Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: June 23, 2015
Early fasting glucose measurements can predict later glycaemic response to once weekly dulaglutide.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: June 03, 2015
Last Updated: 09/26/2026